Xiao Bao

99m Tc-labeling and evaluation of a HYNIC modified small-molecular inhibitor of prostate-specific membrane antigen

Xiaoping Xu, Jianping Zhang, Silong Hu et al. · Nuclear Medicine and Biology · 2017 · 57 citations

Medicine, Medicinal Chemistry, Pharmacology +14

Neoadjuvant Afatinib for stage III EGFR-mutant non-small cell lung cancer: a phase II study

Dongliang Bian, Liangdong Sun, Junjie Hu et al. · Nature Communications · 2023 · 43 citations · Full text

Medicine, Oncology, Pharmacology +17

Optimization of Early Response Monitoring and Prediction of Cancer Antiangiogenesis Therapy via Noninvasive PET Molecular Imaging Strategies of Multifactorial Bioparameters

Xiao Bao, Mingwei Wang, Jian-Min Luo et al. · Theranostics · 2016 · 33 citations · Full text

Medicine, Oncology, Pharmacology +17

18F-fluorodeoxyglucose (FDG) PET/CT after two cycles of neoadjuvant therapy may predict response in HER2-negative, but not in HER2-positive breast cancer

Jingyi Cheng, Yujie Wang, Miao Mo et al. · Oncotarget · 2015 · 29 citations · Full text

Medicine, Oncology, Breast Oncology +12

Multi-functional self-assembled nanoparticles for pVEGF-shRNA loading and anti-tumor targeted therapy

S. Lu, Xiao Bao, Wangxi Hai et al. · International Journal of Pharmaceutics · 2019 · 27 citations · Full text

Pharmacy, Molecular Biology, Pharmaceutics +14